YBX3 Promotes Ischemia-Reperfusion Injury by Enhancing Microglial Glycolysis via PKM2 Stabilization and mTOR-HIF-1α Pathway Activation.
Results identify YBX3 as a key regulator of ischemic brain damage through glycolysis-dependent mechanisms and underscore its potential as a therapeutic target for stroke.